RENOVUE-DIP Drug Patent Profile
✉ Email this page to a colleague
When do Renovue-dip patents expire, and when can generic versions of Renovue-dip launch?
Renovue-dip is a drug marketed by Bracco and is included in one NDA.
The generic ingredient in RENOVUE-DIP is iodamide meglumine. There is one drug master file entry for this compound. Additional details are available on the iodamide meglumine profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for RENOVUE-DIP?
- What are the global sales for RENOVUE-DIP?
- What is Average Wholesale Price for RENOVUE-DIP?
Summary for RENOVUE-DIP
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 11 |
| Patent Applications: | 34 |
| DailyMed Link: | RENOVUE-DIP at DailyMed |
US Patents and Regulatory Information for RENOVUE-DIP
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bracco | RENOVUE-DIP | iodamide meglumine | INJECTABLE;INJECTION | 017903-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
